News & Events

Phathom Pharmaceuticals to Present at 40th Annual Cowen and Company Health Care Conference on March 2, 2020

February 25, 2020

Phathom Pharmaceuticals to Present at 40th Annual Cowen and Company Health Care Conference on March 2, 2020  FLORHAM PARK, NJ.–Feb. 25, 2020– Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced that Terrie Curran, President and Chief Executive

Read More

Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments

September 27, 2019

Terrie Curran, President, Global Inflammation and Immunology Franchise at Celgene Corporation, to succeed David Socks as CEO Michael Cola, Terrie Curran, Heidi Kunz, and Chris Slavinsky appointed to Board of Directors   BUFFALO GROVE, ILLINOIS, September 27, 2019 – Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on the

Read More

Phathom Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference

June 4, 2019

Menlo Park, Calif., June 4, 2019 – Phathom Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders, today announced that David Socks, Chief Executive Officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019

Read More

Media inquiries: If you are a reporter with questions about Phathom Pharmaceuticals, or if you would like to request an interview, please contact: info@phathompharma.com